Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - CVS HEALTH Corp | cvs-20170630ex322a20c5a.htm |
| EX-32.1 - EX-32.1 - CVS HEALTH Corp | cvs-20170630ex3214f53b8.htm |
| EX-31.2 - EX-31.2 - CVS HEALTH Corp | cvs-20170630ex3128a1c97.htm |
| EX-31.1 - EX-31.1 - CVS HEALTH Corp | cvs-20170630ex31122a3a2.htm |
| EX-10.5 - EX-10.5 - CVS HEALTH Corp | cvs-20170630ex105a3120c.htm |
| EX-10.4 - EX-10.4 - CVS HEALTH Corp | cvs-20170630ex1043fff6d.htm |
| EX-10.3 - EX-10.3 - CVS HEALTH Corp | cvs-20170630ex103f2c1a7.htm |
| EX-10.2 - EX-10.2 - CVS HEALTH Corp | cvs-20170630ex1026f1efc.htm |
| EX-10.1 - EX-10.1 - CVS HEALTH Corp | cvs-20170630ex101b6eb7e.htm |
| 10-Q - 10-Q - CVS HEALTH Corp | cvs-20170630x10q.htm |
Letter re: Unaudited Interim Financial Information
August 8, 2017
The Board of Directors and Shareholders:
CVS Health Corporation
We are aware of the incorporation by reference in the Registration Statements (Nos. 333-49407, 333-34927, 333-28043, 333-91253, 333-63664, 333-139470, 333-141481, 333-167746, 333-208805, and 333-217853 on Form S-8, Nos. 333-187440, 333-200217, and 333-217596 on Form S-3ASR, Nos. 333-205156 and 333-210872 on Form S-3 and No. 333-210873 on Form S-4) of CVS Health Corporation of our report dated August 8, 2017, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that are included in its Form 10-Q for the quarter ended June 30, 2017.
|
|
/s/ Ernst & Young LLP |
|
|
|
|
Boston, Massachusetts |
|